Hong Seng Consolidated Berhad 과거 수익 실적

과거 기준 확인 0/6

Hong Seng Consolidated Berhad은 연평균 22.2%의 비율로 수입이 증가해 온 반면, Healthcare 산업은 연평균 21.8%의 비율로 수입이 증가했습니다. 매출은 연평균 33.2%의 비율로 증가했습니다.

주요 정보

22.2%

수익 성장률

35.5%

EPS 성장률

Healthcare 산업 성장	31.5%
매출 성장률	33.2%
자기자본 수익률	-21.9%
순이익	-409.6%
최근 수익 업데이트	31 Mar 2024

최근 과거 실적 업데이트

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Nov 30

Recent updates

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Has Debt But No Earnings; Should You Worry?

Sep 23

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Jun 09

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Oct 12

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?

May 11

We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt

Jan 27

Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching

Jan 04

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Nov 30

Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns

Oct 26

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Aug 31

We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease

Aug 09

수익 및 비용 분석

Hong Seng Consolidated Berhad 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

KLSE:HONGSENG 수익, 비용 및 수입 (MYR Millions )
날짜	수익	수익	G+A 비용
31 Mar 24	15	-61	14
30 Jun 23	9	-27	17
31 Mar 23	12	-3	19
31 Dec 22	126	49	23
30 Sep 22	198	97	25
30 Jun 22	257	135	24
31 Mar 22	258	118	21
31 Dec 21	196	82	17
30 Sep 21	146	44	12
31 Dec 20	27	-4	5
30 Sep 20	2	-7	5
30 Jun 20	3	-8	4
31 Mar 20	4	-7	5
31 Dec 19	5	-7	2
30 Sep 19	8	-13	4
30 Jun 19	10	-14	4
31 Mar 19	10	-13	6
31 Dec 18	16	-26	6
30 Sep 18	24	-20	6
30 Jun 18	26	-24	8
31 Mar 18	29	-27	9
31 Dec 17	27	-10	15
30 Sep 17	27	-12	14
30 Jun 17	29	-11	14
31 Mar 17	30	-8	12
31 Dec 16	31	-8	12
30 Sep 16	38	-3	14
30 Jun 16	39	1	13
31 Mar 16	42	2	14
31 Dec 15	42	4	14
30 Sep 15	39	-2	12
30 Jun 15	39	-5	15
31 Mar 15	38	-5	16
31 Dec 14	36	-9	18
30 Sep 14	33	-2	16
30 Jun 14	35	1	16
31 Mar 14	34	2	16
31 Dec 13	34	4	16

양질의 수익: HONGSENG 은(는) 현재 수익성이 없습니다.

이익 마진 증가: HONGSENG 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: HONGSENG 은(는) 수익성이 없지만 지난 5년 동안 연간 22.2% 의 비율로 손실을 줄였습니다.

성장 가속화: 현재 수익성이 없기 때문에 HONGSENG 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: HONGSENG 은(는) 수익성이 없어 지난 해 수익 성장을 Healthcare 업계( 2.4% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: HONGSENG 현재 수익성이 없기 때문에 마이너스 자본 수익률( -21.92% )을 갖습니다.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/23 01:13
장 마감 주가	2024/12/23 00:00
수익	2024/03/31
연간 수익	2024/03/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Hong Seng Consolidated Berhad 3 애널리스트 중 0 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Terence Wong	CGS International
Shin Kao	OSK-DMG
Swee Tyng Chin	TA Securities Holdings Berhad

Hong Seng Consolidated Berhad 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

Third quarter 2023 earnings released: RM0.001 loss per share (vs RM0.004 profit in 3Q 2022)

Second quarter 2023 earnings released: RM0.002 loss per share (vs RM0.008 profit in 2Q 2022)

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.016 in FY 2021)

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.013 in FY 2021)

Hong Seng Consolidated Berhad Reports Impairment Charges for the Fourth Quarter Ended September 30, 2022

Recent updates

Hong Seng Consolidated Berhad Announces the Resignation of Christopher Chan Hooi Guan as Executive Director

High number of new directors

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Has Debt But No Earnings; Should You Worry?

Less than half of directors are independent

Hong Seng Consolidated Berhad Appoints Yacob Bin Mustafa as Independent and Non Executive Chairman

Hong Seng Consolidated Berhad, Annual General Meeting, Aug 29, 2024

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Less than half of directors are independent

New minor risk - Financial data availability

Hong Seng Consolidated Berhad Announces the Resignation of Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Third quarter 2023 earnings released: RM0.001 loss per share (vs RM0.004 profit in 3Q 2022)

New major risk - Share price stability

Hong Seng Consolidated Berhad Announces Cessation of Teoh Soon Han as Alternate Director

Second quarter 2023 earnings released: RM0.002 loss per share (vs RM0.008 profit in 2Q 2022)

Hong Seng Consolidated Berhad Appoints Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?

Hong Seng Consolidated Berhad entered into a Shares Sale Agreement to acquire Alliance EV Sdn Bhd from CSH Alliance Berhad for MYR 20 million.

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.016 in FY 2021)

Hong Seng Consolidated Berhad agreed to acquire 51% stake in Innov8tif Holdings Sdn Bhd from Innov8tif Consortium Sdn Bhd for MYR 30.9 million.

Hong Seng Consolidated Berhad, Annual General Meeting, Feb 27, 2023

We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt

Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.013 in FY 2021)

Hong Seng Consolidated Berhad Reports Impairment Charges for the Fourth Quarter Ended September 30, 2022

High number of new and inexperienced directors

Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns

Hong Seng Consolidated Berhad Appoints Tea Sor Hua as Company Secretary, Effective October 1, 2022

Hong Seng Consolidated Berhad Announces Re-Designation of Tuan Ng Keok Chai from Member of Remuneration Committee to Chairman of Remuneration Committee

Hong Seng Consolidated Berhad Appoints Dato Kang Chez Chiang as Independent and Non Executive Member of Nomination Committee

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Hong Seng Consolidated Berhad Reports Plant and Equipment Written Off for the Quarter Ended June 30, 2022

Third quarter 2022 earnings released: EPS: RM0.004 (vs RM0.013 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Hong Seng Consolidated Berhad Appoints Dato Mohamed Suffian Bin Awang as Independent and Non Executive Chairman

Hong Seng Consolidated Berhad, Annual General Meeting, Feb 25, 2022

Second quarter 2022 earnings: Revenues miss analyst expectations

Robust Potential Sdn Bhd entered into an agreement to acquire Hong Seng Priority Management Sdn Bhd from Hong Seng Consolidated Berhad (KLSE:HONGSENG) for MYR 34.5 million.

Senior Independent Non-Executive Director Mun Wong has left the company

Full year 2021 earnings released: EPS RM0.022 (vs RM0.025 loss in FY 2020)

Hong Seng Consolidated Berhad Announces Appointment of Mr. Christopher Chan Hooi Guan as Executive Director

Independent Non Executive Director has left the company

Hong Seng Consolidated Berhad Resigns Ym Tengku Farith Rithauddeen as Independent and Non Executive Independent Director

Hong Seng Consolidated Berhad Resigns Tengku Farith Rithauddeen as Independent and Non Executive Chairman of Nomination Committee

Third quarter 2021 earnings released: EPS RM0.006 (vs RM0.002 loss in 3Q 2020)

Hong Seng Consolidated Berhad Announces Resignation of Mr. Lim Peng Tong as Executive Director

New 90-day high: RM1.35

New 90-day high: RM1.15

Second quarter 2021 earnings released: EPS RM0.003

New 90-day low: RM0.99

Hong Seng Consolidated Berhad (KLSE:HONGSENG) entered into a share sale agreement to acquire remaining 49% stake in HS Bio Supplies Sdn Bhd from United ICT Consortium Sdn. Bhd. For MYR 0.98 million.

MSCM Holdings Berhad Announces Cessation of Wong Yee Ming as Non-Independent and Non-Executive Alternate Director

First quarter earnings released

New 90-day high - RM1.50

Landasan Simfoni Sdn Bhd entered into a share sale agreement to acquire 47.19% sake in MSCM Holdings Berhad (KLSE:MYSCM) from MMag Holdings Berhad (KLSE:MMAG) for MYR 0.75 million.

New 90-day high - RM0.20

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률

자산 수익률

고용 자본 수익률